Homology Medicines, Inc.
Simbol: 0T6G.L
LSE
21.56
USDTržna cena danes
-0.7390
Razmerje P/E
-0.0083
Razmerje PEG
283.62M
Kapaciteta MRK
- 0.00%
Donos DIV
Homology Medicines, Inc. (0T6G-L) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 82.7 | 175 | 155.9 | ||||||||
balance-sheet.row.short-term-investments | 0 | 43.4 | 141 | 47.5 | ||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.other-current-assets | 0 | 1.3 | 6 | 36 | ||||||||
balance-sheet.row.total-current-assets | 0 | 83.9 | 181 | 191.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0.7 | 21.6 | 17.9 | ||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 25.8 | 2 | ||||||||
balance-sheet.row.tax-assets | 0 | 221.6 | 0 | 0 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 222.2 | 47.5 | 19.8 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 306.1 | 228.5 | 211.7 | ||||||||
balance-sheet.row.account-payables | 0 | 3.2 | 1.1 | 2.4 | ||||||||
balance-sheet.row.short-term-debt | 0 | 1.3 | 1.6 | 0.2 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 49.4 | 11.9 | 5 | ||||||||
Deferred Revenue Non Current | 0 | -104.4 | 0 | 1.2 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 7 | 18.7 | 11.4 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 221.6 | 27.9 | 24.8 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 6.8 | 27.9 | 23.7 | ||||||||
balance-sheet.row.total-liab | 0 | 233.1 | 50.5 | 42.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 111.4 | 111.4 | 111.4 | ||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.retained-earnings | 0 | -542.1 | -429.1 | -424.1 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.4 | 0 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 503.6 | 496.1 | 482.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 73 | 178 | 169.7 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 306.1 | 228.5 | 211.7 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 73 | 178 | 169.7 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 43.4 | 166.9 | 49.4 | ||||||||
balance-sheet.row.total-debt | 0 | 1.3 | 29.5 | 23.9 | ||||||||
balance-sheet.row.net-debt | 0 | -37.9 | -4.5 | -84.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -113 | -5 | -95.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.6 | 2.6 | 9.5 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -19.2 | -38.8 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 13.1 | 17.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -7.2 | 3.4 | -41.8 | ||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 2.1 | -1 | -2.5 | ||||||||
cash-flows.row.other-working-capital | 0 | -9.3 | 4.3 | -39.3 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 23.4 | -108.4 | 39.8 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.2 | -1.3 | -2.4 | ||||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 130 | 48.4 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -73.2 | -157.5 | -97.4 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 174.2 | 65.5 | 49 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -48.4 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 101.3 | 36.7 | -50.8 | ||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0.6 | 52.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0.6 | 52.2 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0.2 | 0.6 | 52.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 5.3 | -74.4 | -109 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 39.3 | 34 | 108.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 34 | 108.4 | 217.4 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -96.2 | -113.7 | -109.8 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.2 | -1.3 | -2.4 | ||||||||
cash-flows.row.free-cash-flow | 0 | -96.5 | -114.9 | -112.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1.2 | 3.2 | 34 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 0.6 | 2.6 | 9.5 | ||||||||
income-statement-row.row.gross-profit | 0 | 0.6 | 0.6 | 24.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 92.7 | 133.9 | 120.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 93.3 | 136.5 | 129.9 | ||||||||
income-statement-row.row.interest-income | 0 | 5.6 | 3.2 | 0.2 | ||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 5 | 134.5 | 0.2 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | 5 | 134.5 | 0.2 | ||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.6 | 2.6 | 9.5 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -92.1 | -133.3 | -95.9 | ||||||||
income-statement-row.row.income-before-tax | 0 | -87.1 | 1.2 | -95.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 0.3 | 0.7 | 0.5 | ||||||||
income-statement-row.row.net-income | 0 | -113 | -5 | -95.8 |
Pogosto zastavljeno vprašanje
Kaj je Homology Medicines, Inc. (0T6G.L) skupna sredstva?
Homology Medicines, Inc. (0T6G.L) skupna sredstva so 306119000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 2.827.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -22.864.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 8.364.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 6.819.
Kaj je Homology Medicines, Inc. (0T6G.L) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -112961000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 1318000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 92680000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.